Tracked shipping to South Africa with premium packaging for just R199 

Ship to
South Africa
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment. Proceedings of a Workshop
Type
Physical Book
Publisher
Author
Year
2016
Pages
134
Format
Paperback
Dimensions
22.9x15.2x2.5 cm
ISBN13
9780309442329

Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment. Proceedings of a Workshop

Board On Health Care Services;Sharyl J. Nass;Margie Patlak;Kimberly Maxfield;Erin Balogh;National Cancer Policy Forum;Health And Medicine Division;Engineering, And Medicine National Academies Of Sciences (Author) · National Academies Press · Paperback

Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment. Proceedings of a Workshop - Board on Health Care Services;Sharyl J. Nass;Margie Patlak;Kimberly Maxfield;Erin Balogh;National Cancer Policy Forum;Health and Medicine Division;Engineering, and Medicine National Academies of Sciences

New Book Imported to South Africa
Delivery: 02 Oct - 12 Oct Shipping: 2 to 3 business days.
R 873
R 873

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment. Proceedings of a Workshop"

Immunotherapy is a form of cancer therapy that harnesses the body's immune system to destroy cancer cells. In recent years, immunotherapies have been developed for several cancers, including advanced melanoma, lung cancer, and kidney cancer. In some patients with metastatic cancers who have not responded well to other treatments, immunotherapy treatment has resulted in complete and durable responses. Given these promising findings, it is hoped that continued immunotherapy research and development will produce better cancer treatments that improve patient outcomes. With this promise, however, there is also recognition that the clinical and biological landscape for immunotherapies is novel and not yet well understood. For example, adverse events with immunotherapy treatment are quite different from those experienced with other types of cancer therapy. Similarly, immunotherapy dosing, therapeutic responses, and response time lines are also markedly different from other cancer therapies. To examine these challenges and explore strategies to overcome them, the National Academies of Sciences, Engineering, and Medicine held a workshop in February and March of 2016. This report summarizes the presentations and discussions from the workshop. Table of ContentsFront MatterProceedings of a WorkshopAppendix A: Statement of TaskAppendix B: Workshop AgendaAppendix C: Glossary

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

What is the format of this book?

The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews